Navigation Links
Brain Imaging Study Confirms Cognizin(R) Citicoline Boosts Mental Function; to be Presented at International Society of Sports Nutrition Annual Conference
Date:6/8/2009

Natural Compound Proven to Improve Memory, Spark Energy and Protect Against Mental 'Burn Out' that Accompanies Aging

NEW ORLEANS, June 8 /PRNewswire/ -- A recent study out of McLean Hospital, an affiliate of Harvard Medical School, confirms that Cognizin(R) Citicoline, a dietary supplement composed of a powerful natural anti-aging compound, that has been shown to support the improvement of brain function by promoting neural and cognitive performance, will be presented at this year's International Society of Sports Nutrition Annual Conference in New Orleans by Dr. Deborah Yurgelun-Todd on Tuesday, June 16, 2009. The International Society of Sports Nutrition is the only non-profit academic society dedicated to promoting the science and application of evidence-based sports nutrition and supplementation.

The study, entitled "Citicoline Enhances Frontal Lobe Bioenergetics as Measured by Phosphorus Magnetic Resonance Spectroscopy," was published in the Journal of NMR in BioMedicine (Vol 21, Issue 10, Dec 2008, 1066-1075). The citicoline used in the study is manufactured by Kyowa Hakko, an international health ingredients manufacturer, using a proprietary formula under the brand name Cognizin(R).

Several prior studies of Cognizin(R) Citicoline, as well as this one conducted at McLean Hospital, a Harvard Medical School affiliate in early 2008 and presented at the Society for Neuroscience's 37th Annual Meeting, demonstrated the supplement's effectiveness in providing essential structural components for synthesizing brain cell membranes and helping subjects maintain normal cognitive function as they age. It achieves these results by increasing the production of several neurotransmitters in the central nervous system, including acetylcholine, norepinephrine and dopamine.

In the study, 16 subjects were randomly chosen to receive 500 mg and 2000 mg daily of Cognizin(R) Citicoline for six weeks. The benefits observed were quantified by sophisticated brain imaging techniques, which showed healthy middle-aged adults had increased energy and electrical activity in the frontal lobe of the brain - the portion of the brain that controls higher thought, decision making and focus. The new study is more specific than earlier studies about citicoline's beneficial effect on the brain. It also appears to forge a stronger link than ever between nutrition and cognitive function, a relationship that has often been discounted in the past.

"This most recent study confirms previous research and bolsters our conviction that citicoline, taken at a minimum dosage of 500 mg each day, is a simple and natural nutrient for your brain that may help you feel better, think more clearly, sleep better, increase your memory and improve your overall quality of life," said Perry Renshaw, M.D., Ph.D. Director of Magnetic Resonance Imaging, The Brain Institute of the University of Utah, Professor of Psychiatry, University of Utah School of Medicine and a pioneer in research on the compound.

Dr. Deborah Yurgelun-Todd, Director of Cognitive Neuroimaging at the Brain Institute of the University of Utah and Professor of Psychiatry, was the lead investigator of the study. "We're excited about some of the ancillary benefits we're seeing that have implications for improved attention, increased energy and even weight loss in our subjects," says Dr. Yurgelun-Todd. "We were very selective about the form of citicoline that we used in our study. We looked at several forms and delivery systems of citicoline, and we ultimately used Cognizin(R) Citicoline because of its purity and consistent quality. We cannot stand behind other forms of citicoline, as we have not tested their quality and purity," Dr. Yurgelun-Todd ends.

Citicoline is a generic name for supplemental CDP-choline, a natural substance found in all living cells. In human health, CDP-choline plays important roles in the formation of cell membranes and in supporting healthy brain function. Citicoline is sometimes called a "brain nutrient" because of its roles in supporting cognition and memory. To learn more, please go to: http://www.cognizin.com/.

About Kyowa Hakko

Kyowa Hakko offers manufacturers and formulators one of the industry's most extensive lines of more than 50 amino acids and related compounds, including D-Amino acids and branched-chain amino acids, as well as nucleic acids, bio-products and fine chemicals. Kyowa Hakko also offers an array of branded ingredients including Cognizin(R) Citicoline, Kyowa CoQ10(R), Lumistor(R) L-Hydroxyproline, Hydrafend(TM) Hyaluronic Acid, Setria(R) Glutathione and Sustamine(TM) L-Alanyl Glutamine. For more information, please visit: http://www.kyowa-usa.com

Journal Citation:

Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy

NMR in Biomedicine

Volume 21, Issue 10, Date: December 2008, Pages: 1066-1075

M. M. Silveri, J. Dikan, A. J. Ross, J. E. Jensen, T. Kamiya, Y. Kawada, P. F. Renshaw, D. A. Yurgelun-Todd

    Contact:  Margie Adelman
    Adelman Public Relations
    916 220 3500 cell


'/>"/>
SOURCE Kyowa Hakko
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marbles: The Brain Store Opens New Location in Chicago, Introduces World's First Bike that Trains Body and Brain
2. Some OTC Sleep, Cold Meds Could Harm Aging Brain
3. Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI, GE Healthcare MR Surgical Technology
4. Fewer Deaths Occurring From Brain Bleeds
5. Could standard treatment for traumatic brain injury be wrong?
6. The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer
7. Voices Against Brain Cancer Hosts Event to Benefit Brain Cancer Research
8. Study further expands understanding of leptins role in brain neurocircuitry
9. UCF researcher developing computer program to detect, measure brain tumors
10. Most common brain cancer may start in neural stem cells
11. Outsmarting Brain Tumors: Cedars-Sinai Researchers, Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the fear ... political games that circumvent health needs of over 30 million. Many interviews with Dr. ... and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital ... the American Heart Association (AHA) to produce a three-part video series that uses humor ... as part of the launch of AHA’s Healthy For Good™ movement, which is designed ...
(Date:1/19/2017)... ... 19, 2017 , ... Dr. Andrew Lian-Jie Li ... trained Mohs and cosmetic surgeon. After extensive dermatology research training at the National ... in internal medicine at the Emory University and dermatology training at the University ...
(Date:1/19/2017)... Beach, CA (PRWEB) , ... January 19, 2017 ... ... Oral Health, is now offering treatments for patients with sleep apnea and TMJ ... consequences for dental and physical health. Dr. Rassouli provides personalized care to reduce ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree Brady Insurance Agency, ... communities throughout eastern Georgia, is embarking on a charity effort to raise awareness ... more Americans every year than anything else, yet risk factors associated with heart ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... , Jan. 18, 2017  ViewRay, Inc. (Nasdaq: ... first and only clinical MRI-guided radiation therapy system, announced ... of approximately $26.1 million through a private placement ... Management led the financing and was joined by ... LLC and Kearny Venture Partners, and an additional ...
(Date:1/19/2017)... 18, 2017 The Academy of Managed ... Administration (FDA) for its release today of draft ... decision makers can proactively share clinical and economic ... as emerging therapies awaiting FDA approval. ... that AMCP developed during two multi-stakeholder meetings last ...
Breaking Medicine Technology: